Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun 26;24(1):640.
doi: 10.1186/s12879-024-09547-y.

Recent increase in atypical presentations of invasive meningococcal disease in France

Affiliations

Recent increase in atypical presentations of invasive meningococcal disease in France

Samy Taha et al. BMC Infect Dis. .

Abstract

Background: Invasive meningococcal disease (IMD) cases declined upon the implementation of non-pharmaceutical interventions (NPI) (social distancing and mask wearing) to control the COVID-19 pandemic but rebounded in 2022 in numbers with genotypical changes of the strains. We explored here associated modifications in the clinical presentations of IMD.

Methods: We conducted a retrospective descriptive study using the Database of the French National Reference Centre for meningococci and Haemophilus influnezae for IMD cases between 2015 and 2022. We scored serogroups, sex, age groups, clinical presentations and clonal complexes of the corresponding patients and isolates.

Findings: Non-meningeal forms of IMD increased significantly upon easing of NPI, such as bacteremic meningococcal pneumonia and bacteremic abdominal forms. They represented 6% and 8% of all IMD forms and were significantly linked to serogroups Y and W respectively, to older adults for bacteremic pneumonia and to young adults for bacteremic abdominal presentations. These forms were significantly associated with more early mortality and clonal complexes 23, 11 and 9316.

Interpretation: The increase in atypical IMD forms may lead to higher burden of IMD due to delayed diagnosis and management. Updating prevention may be needed through by adapting the current vaccination strategies to epidemiological changes.

Keywords: Neisseria meningitidis; COVID-19; Clinical presentation; Epidemiology; Invasive meningococcal disease.

PubMed Disclaimer

Conflict of interest statement

MKT performs contract works for the Institut Pasteur funded by GSK, Sanofi and Pfizeroutside the submitted manuscript, and MKT and AED have a patent with GSK, 630133. ST was a recipient of a fellowship from Pfizer that had no role in the data collection, interpretation, or writing of the manuscript.

Figures

Fig. 1
Fig. 1
Distribution of clinical presentations of IMD per year in France, 2015–2022
Fig. 2
Fig. 2
Evolution of IMD clinical presentations by serogroup, France, 2015–2022
Fig. 3
Fig. 3
Distribution of clinical presentations by age group, France, 2015–2022. (number of cases are indicated in the bars)
Fig. 4
Fig. 4
Distribution of clinical presentations by clonal complex, France, 2015–2022. (number of cases are indicated in the bars)
Fig. 5
Fig. 5
Distribution of early deaths by IMD clinical presentation, France, 2015–2022
Fig. 6
Fig. 6
Distribution of serogroup B clinical presentations by age group, France, 2015–2022. (number of cases are indicated in the bars)
Fig. 7
Fig. 7
Distribution of serogroup C clinical presentations by age group, France, 2015–2022 (number of cases are indicated in the bars)
Fig. 8
Fig. 8
Distribution of serogroup W clinical presentations by age group, France, 2015–2022. (number of cases are indicated in the bars)
Fig. 9
Fig. 9
Distribution of serogroup Y clinical presentations by age group, France, 2015–2022. (number of cases are indicated in the bars)

References

    1. Yazdankhah SP, Caugant DA. Neisseria meningitidis: an overview of the carriage state. J Med Microbiol. 2004;53(Pt 9):821–32. - PubMed
    1. ECDC. Invasive meningococcal disease- annual epidemiological report for 2018. In: Annual Epidemiological Report for 2017. ECDC; 2019.
    1. Rosenstein NE, Perkins BA, Stephens DS, Popovic T, Hughes JM. Meningococcal disease. N Engl J Med. 2001;344(18):1378–88. doi: 10.1056/NEJM200105033441807. - DOI - PubMed
    1. Yazdankhah SP, Kriz P, Tzanakaki G, Kremastinou J, Kalmusova J, Musilek M, Alvestad T, Jolley KA, Wilson DJ, McCarthy ND, et al. Distribution of serogroups and genotypes among Disease-Associated and carried isolates of Neisseria meningitidis from the Czech Republic, Greece, and Norway. J Clin Microbiol. 2004;42(11):5146–53. doi: 10.1128/JCM.42.11.5146-5153.2004. - DOI - PMC - PubMed
    1. Stinson C, Burman C, Presa J, Abalos M. Atypical presentation of invasive meningococcal disease caused by serogroup W meningococci. Epidemiol Infect. 2020;148:e12. doi: 10.1017/S0950268819002152. - DOI - PMC - PubMed

MeSH terms

Grants and funding